Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
about
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaEvaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsisClinical significance of microbial infection and adaptation in cystic fibrosis.Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatmentsImmunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis.Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection.
P2860
Q29615286-CAF64D6D-50CA-4871-A0DA-932C2AB8B011Q33613907-B781E7EE-F5D7-4401-8E16-A961558A7B3BQ33893648-9C576BEB-7ACD-4846-A50C-A5472B31CE06Q34006764-FD87AAD3-2C12-46CB-8285-A1A6CB0C7424Q34491552-97CE6FAF-F051-4126-962A-625AD4932687Q34523901-C710E360-DE97-4B7A-B0BC-7BAF596F72DCQ34532344-1AF94F90-D298-42FD-A3DC-8A23096D2DF8Q34537794-5CDB912A-ABC4-4F2D-A6FE-24E28842FB58Q35106317-F476C227-F5C4-4FA0-98FE-FEDC10DB029DQ35139384-7A3EE607-2A01-486E-BC72-259A3548E8E6Q37620529-39A6A3FC-84F0-4316-8ED1-4577FB0BB13DQ39519011-94F19718-5D3C-4448-AE55-E5D4C58666B7Q40149473-33FC152D-CD14-47ED-81E8-1B1682E4D2BDQ41909195-B40588CA-6531-41F9-A39F-030E9F5A15EE
P2860
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
@en
type
label
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
@en
prefLabel
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
@en
P2860
P1476
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
@en
P2093
C V Garner
D DesJardins
P2860
P304
P407
P50
P577
1990-06-01T00:00:00Z